<?xml version='1.0' encoding='utf-8'?>
<document id="27910730"><sentence text="Retrospective use of PBPK modelling to understand a clinical drug-drug interaction between dextromethorphan and GSK1034702."><entity charOffset="91-107" id="DDI-PubMed.27910730.s1.e0" text="dextromethorphan" /><entity charOffset="112-122" id="DDI-PubMed.27910730.s1.e1" text="GSK1034702" /><pair ddi="false" e1="DDI-PubMed.27910730.s1.e0" e2="DDI-PubMed.27910730.s1.e0" /><pair ddi="false" e1="DDI-PubMed.27910730.s1.e0" e2="DDI-PubMed.27910730.s1.e1" /></sentence><sentence text="1" /><sentence text=" In a clinical trial, a strong drug-drug interaction (DDI) was observed between dextromethorphan (DM, the object or victim drug) and GSK1034702 (the precipitant or perpetrator drug), following single and repeat doses"><entity charOffset="80-96" id="DDI-PubMed.27910730.s3.e0" text="dextromethorphan" /></sentence><sentence text=" This study determined the inhibition parameters of GSK1034702 in vitro and applied PBPK modelling approaches to simulate the clinical observations and provide mechanistic hypotheses to understand the DDI" /><sentence text=" 2" /><sentence text=" In vitro assays were conducted to determine the inhibition parameters of human CYP2D6 by GSK1034702" /><sentence text=" PBPK models were populated with the in vitro parameters and DDI simulations conducted and compared to the observed data from a clinical study with DM and GSK1034702" /><sentence text=" 3" /><sentence text=" GSK1034702 was a potent direct and metabolism-dependent inhibitor of human CYP2D6, with inhibition parameters of: IC50 = 1" /><sentence text="6 μM, Kinact = 3" /><sentence text="7 h-1 and KI = 0" /><sentence text="8 μM" /><sentence text=" Incorporating these data into PBPK models predicted a DDI after repeat, but not single, 5 mg doses of GSK1034702" /><sentence text=" 4" /><sentence text=" The DDI observed with repeat administration of GSK1034702 (5 mg) can be attributed to metabolism-dependent inhibition of CYP2D6" /><sentence text=" Further, in vitro data were generated and several potential mechanisms proposed to explain the interaction observed following a single dose of GSK1034702" /><sentence text="" /></document>